The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Sanders, Jan-Stephan FBemelman, Frederike J
Messchendorp, A Lianne
Baan, Carla C
van Baarle, Debbie
van Binnendijk, Rob
Diavatopoulos, Dimitri A
Frölke, Sophie C
Geers, Daryl
GeurtsvanKessel, Corine H
den Hartog, Gerco
van der Heiden, Marieke
Imhof, Celine
Kho, Marcia M L
Koopmans, Marion P G
Malahe, S Reshwan K
Mattheussens, Wouter B
van der Molen, Renate
van Mourik, Djenolan
Remmerswaal, Ester B M
Rots, Nynke
Vart, Priya
de Vries, Rory D
Gansevoort, Ron T
Hilbrands, Luuk B
Reinders, Marlies E J
Type
ArticleOther
Language
en
Metadata
Show full item recordTitle
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.Published in
Transplantation 2022 ; 106(4):821-34PMID
34753894ae974a485f413a2113503eed53cd6c53
10.1097/TP.0000000000003983
Scopus Count
Collections
Related articles
- Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study.
- Authors: Bouwmans P, Messchendorp AL, Sanders JS, Hilbrands L, Reinders MEJ, Vart P, Bemelman FJ, Abrahams AC, van den Dorpel MA, Ten Dam MA, de Vries APJ, Rispens T, Steenhuis M, Gansevoort RT, Hemmelder MH, RECOVAC Collaborators
- Issue date: 2022 Feb 5
- Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
- Authors: Sanders JF, Messchendorp AL, de Vries RD, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Geers D, Schmitz KS, GeurtsvanKessel CH, den Hartog G, Kho MML, Koopmans MPG, van der Molen RG, Remmerswaal EBM, Rots N, Gansevoort RT, Bemelman FJ, Hilbrands LB, Reinders MEJ, VACcination Immune Response Study (RECOVAC) Collaborators
- Issue date: 2023 Feb 8
- Systemic oxidative stress may be associated with reduced IgG antibody titers against SARS-CoV-2 in vaccinated kidney transplant recipients: A post-hoc analysis of the RECOVAC-IR observational study.
- Authors: van Eijk LE, Bourgonje AR, Messchendorp AL, Bulthuis MLC, Reinders-Luinge M, Doornbos-van der Meer B, Westra J, den Dunnen WFA, Hillebrands JL, Sanders JF, van Goor H, RECOVAC Collaborators
- Issue date: 2024 Mar
- Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients.
- Authors: Kolb T, Fischer S, Müller L, Lübke N, Hillebrandt J, Andrée M, Schmitz M, Schmidt C, Küçükköylü S, Koster L, Kittel M, Weiland L, Dreyling KW, Hetzel G, Adams O, Schaal H, Ivens K, Rump LC, Timm J, Stegbauer J
- Issue date: 2021 Sep 30
- The RECOVAC IR study: the immune response and safety of the mRNA-1273 COVID-19 vaccine in patients with chronic kidney disease, on dialysis or living with a kidney transplant.
- Authors: Kho MML, Reinders MEJ, Baan CC, van Baarle D, Bemelman FJ, Diavatopoulos DA, Gansevoort RT, van der Klis FRM, Koopmans MPG, Messchendorp AL, van der Molen RG, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Hilbrands LB, Sanders JF, RECOVAC Collaborators
- Issue date: 2021 Aug 27